Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Pamela H. Koerner"'
Publikováno v:
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Vol 13 (2019)
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease which results in thickening and scarring of the interstitial tissue. As the only 2 Food and Drug Administration (FDA)-approved medications on the market, it is valuable to com
Externí odkaz:
https://doaj.org/article/77d3e135787e4ca5b3f06be7ef7f148b
Publikováno v:
Journal of Drug Assessment
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Objective The purpose of this study is to review CDK 4/6 inhibitors used to treat metastatic breast cancer for patient safety, cost and utilization. By evaluating patient outcomes and payer influence, this study will provide critical information to a
Publikováno v:
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Vol 13 (2019)
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Vol 13 (2019)
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease which results in thickening and scarring of the interstitial tissue. As the only 2 Food and Drug Administration (FDA)-approved medications on the market, it is valuable to com
Publikováno v:
Journal of Pharmacy Practice. 30:154-161
Background: The hepatitis C virus (HCV) is the most common chronic blood-borne infection and the leading cause of liver transplantation in the United States. There are approximately 3.2 million people currently infected with HCV in the United States.
Publikováno v:
Journal of Drug Assessment
Background: Hemophilia A is a genetic bleeding disorder caused by a deficiency in factor VIII (FVIII). FVIII maintains bleeding homeostasis within the body through its downstream effects on the intrinsic clotting cascade. The extent of the disease
Publikováno v:
Journal of Oncology Pharmacy Practice. 22:68-75
Background The cycle management program (CMP) was implemented in 2008 at a national specialty pharmacy with a focus on providing specialized counseling and monitoring for patients on select oral oncology medications. The program now includes nine med
Publikováno v:
Value in Health. 18(3):A163-A164
Publikováno v:
Journal of Gastroenterology, Pancreatology & Liver Disorders. 1
Objective: To analyze the SVR rates and medication experience in patients treated with boceprevir or telaprevir, in combination with ribavirin and peginterferon alfa for HCV infection. Materials and methods: This study was a retrospective observation
Publikováno v:
Value in Health. 19:A18
Publikováno v:
Value in Health. 18:A164